These authors contributed equally to this work.
Article first published online: 14 MAY 2013
Copyright © 2013 American Association for the Study of Liver Diseases
Volume 57, Issue 6, pages 2235–2247, June 2013
How to Cite
Huang, X.-Y., Ke, A.-W., Shi, G.-M., Zhang, X., Zhang, C., Shi, Y.-H., Wang, X.-Y., Ding, Z.-B., Xiao, Y.-S., Yan, J., Qiu, S.-J., Fan, J. and Zhou, J. (2013), αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma. Hepatology, 57: 2235–2247. doi: 10.1002/hep.26255
Potential conflict of interest: Nothing to report.
- Issue published online: 12 JUN 2013
- Article first published online: 14 MAY 2013
- Accepted manuscript online: 12 JAN 2013 07:10AM EST
- Manuscript Accepted: 13 DEC 2012
- Manuscript Received: 5 NOV 2012
- The National Science Foundation for Distinguished Young Scholars of China. Grant Number: 81225019
- Major Program of National Natural Science Foundation of China. Grant Number: 81030038
- National Key Sci-Tech Project. Grant Number: 2012ZX10002-016
- NSFC. Grant Numbers: 81071741, 81172023, 81172277, 81272574, 30972949
Additional Supporting Information may be found in the online version of this article.
|HEP_26255_sm_SuppFig1.tif||695K||Supporting Information Figure 1.|
|HEP_26255_sm_SuppFig2.tif||1133K||Supporting Information Figure 2.|
|HEP_26255_sm_SuppFig3.tif||710K||Supporting Information Figure 3.|
|HEP_26255_sm_SuppFig4.tif||2476K||Supporting Information Figure 4.|
|HEP_26255_sm_SuppTab1.doc||76K||Supporting Information Table 1. siRNA target sequences.|
|HEP_26255_sm_SuppTab2.doc||44K||Supporting Information Table 2. Sequence of primers for RT-PCR and qRT-PCR.|
|HEP_26255_sm_SuppTab3.doc||70K||Supporting Information Table 3. Primary antibodies for western blot, IHC and co-IP.|
|HEP_26255_sm_SuppTab4.doc||72K||Supporting Information Table 4. Correlation between Cryab and clinicopathological characteristics in 403 HCCs.|
|HEP_26255_sm_SuppTab5.doc||164K||Supporting Information Table 5. The signifacant pathways related to Cryab based on the data base KEGG and Biocarta respectively.|
|HEP_26255_sm_SuppTab6.doc||47K||Supporting Information Table 6. Demographic and Baseline Characteristics of the Patients (Sorafenib-Treated Population).|
|HEP_26255_sm_SuppTab7.doc||47K||Supporting Information Table 7. HCCLM3 LC-MS protein associated with MAPK.|
|HEP_26255_sm_SuppTab8.doc||45K||Supporting Information Table 8. Hep3B-Cryab LC-MS protein associated with MAPK.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.